MRM-3379

N/A

Report date: 2025/10/09 20:00:09
NME

Base Information

Drug NameMRM-3379
Drug Alias NameDNS-3379ENT-3379MRM-3379
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActioncAMP-specific 3',5'-cyclic phosphodiesterase 4D inhibitors
TargetscAMP-specific 3',5'-cyclic phosphodiesterase 4D
Therapy Area/IndicationsIschemic StrokeFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDart Neuroscience Llc
China Registration ClassN/A

Develop Information

Active CompaniesMirum Pharmaceuticals Inc
Inactive CompaniesDart Neuroscience Llc
Active IndicationsFragile X Syndrome
Inactive IndicationsIschemic Stroke

Other Information

ATC CodeN/A
Related LinksN/A